{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:37:25Z","timestamp":1769578645982,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jfma.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:31:26Z","timestamp":1744133486000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression"],"prefix":"10.1016","volume":"125","author":[{"given":"Bing-Yi","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1887-5486","authenticated-orcid":false,"given":"IShin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-1699","authenticated-orcid":false,"given":"Chi-Tai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41467-024-47451-w","article-title":"Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin","volume":"15","author":"Pu\u0161nik","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jfma.2025.04.002_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad209","article-title":"Effectiveness of the coronavirus disease 2019 bivalent vaccine","volume":"10","author":"Shrestha","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.jfma.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/cid\/ciac327","article-title":"Coronavirus disease 2019 vaccine boosting in previously infected or vaccinated individuals","volume":"75","author":"Shrestha","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jfma.2025.04.002_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25320","article-title":"Rate of SARS-CoV-2 reinfection during an omicron wave in Iceland","volume":"5","author":"Eythorsson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"Suppl 2","key":"10.1016\/j.jfma.2025.04.002_bib5","article-title":"COVID-19 primary series and booster vaccination and potential for immune imprinting","volume":"10","author":"Chemaitelly","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jfma.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jfma.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/14760584.2022.2130773","article-title":"Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis","volume":"21","author":"Meggiolaro","year":"2022","journal-title":"Expet Rev Vaccine"},{"key":"10.1016\/j.jfma.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/vaccines11020224","article-title":"A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron variant (B.1.1.529)","volume":"11","author":"Mohammed","year":"2023","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.jfma.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","article-title":"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022","volume":"11","author":"Wu","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jfma.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/vaccines10091396","article-title":"Effectiveness of COVID-19 vaccine booster shot compared with non-booster: a meta-analysis","volume":"10","author":"Zhu","year":"2022","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.jfma.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ajic.2023.02.005","article-title":"Effectiveness of mRNA vaccine against Omicron-related infections in the real world: a systematic review and meta-analysis","volume":"51","author":"Guo","year":"2023","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jfma.2025.04.002_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3390\/vaccines10122180","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 omicron variant (B.1.1.529): a systematic review with meta-analysis and meta-regression","volume":"10","author":"Pratama","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jfma.2025.04.002_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.940956","article-title":"The vaccine efficacy against the SARS-CoV-2 omicron: a systemic review and meta-analysis","volume":"10","author":"Zou","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jfma.2025.04.002_bib14","series-title":"Living guidance for clinical management of COVID-19, November 23, 2021. Availabile at: guideline Clinical management of COVID-19 patients: living guideline","year":"2021"},{"key":"10.1016\/j.jfma.2025.04.002_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.jfma.2025.04.002_bib16","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.jfma.2025.04.002_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jfma.2025.04.002_bib18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.jfma.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(22)00092-7","article-title":"Three-dose vaccination elicits neutralising antibodies against omicron","volume":"399","author":"Wu","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.04.002_bib20","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.7150\/ijbs.73583","article-title":"Humoral and Cellular immune responses of COVID-19 vaccines against SARS-Cov-2 omicron variant: a systemic review","volume":"18","author":"Chen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jfma.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/vaccines10071101","article-title":"Neutralization activity against SARS-CoV-2 variants after booster vaccination in populations without COVID-19: a meta-analysis","volume":"10","author":"Cheng","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jfma.2025.04.002_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.04.002_bib23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41467-023-37176-7","article-title":"Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis","volume":"14","author":"Cromer","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jfma.2025.04.002_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28164","article-title":"Vaccine\u2010induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster","volume":"95","author":"Favresse","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2025.04.002_bib25","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.jfma.2025.04.002_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine\u2013induced immunity","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jfma.2025.04.002_bib27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/vaccines10101757","article-title":"Post-vaccination neutralization responses to omicron sub-variants","volume":"10","author":"Jacobsen","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.jfma.2025.04.002_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jfma.2025.04.002_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm7349a2","article-title":"Use of additional doses of 2024\u20132025 COVID-19 vaccine for adults aged \u226565 Years and persons aged \u22656 Months with moderate or severe immunocompromise: recommendations of the advisory committee on immunization practices \u2014 United States, 2024","volume":"73","author":"Roper","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:01:20Z","timestamp":1769518880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0929664625001482"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.04.002","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}